These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Capillary neoformation in the heart and skeletal muscle during dipyridamole--treatment and exercise. Tornling G Acta Pathol Microbiol Immunol Scand Suppl; 1982; 278():1-63. PubMed ID: 6960638 [No Abstract] [Full Text] [Related]
4. Proliferative activity of capillary wall cells in skeletal muscle of rats during long-term treatment with dipyridamole. Tornling G; Unge G; Adolfsson J; Ljungqvist A; Carlsson S Arzneimittelforschung; 1980; 30(4):622-3. PubMed ID: 7190403 [TBL] [Abstract][Full Text] [Related]
5. Dipyridamole-induced capillary endothelial cell proliferation in the rat heart--a morphometric investigation. Mattfeldt T; Mall G Cardiovasc Res; 1983 Apr; 17(4):229-37. PubMed ID: 6871913 [TBL] [Abstract][Full Text] [Related]
6. Capillary neoformation in the heart of dipyridamole-treated rats. Tornling G Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):269-71. PubMed ID: 7124398 [TBL] [Abstract][Full Text] [Related]
7. Dipyridamole-induced neoformation of capillaries in the rat heart. Quantitative stereological study on papillary muscles. Mall G; Schikora I; Mattfeldt T; Bodle R Lab Invest; 1987 Jul; 57(1):86-93. PubMed ID: 2439774 [TBL] [Abstract][Full Text] [Related]
8. Induction of capillary neoformation in the heart and skeletal muscle. Ljungqvist A; Adolfsson J Morphol Embryol (Bucur); 1988; 34(4):291-5. PubMed ID: 2467200 [No Abstract] [Full Text] [Related]
9. Capillary neoformation in skeletal muscle of dipyridamole-treated rats. Tornling G; Adolfsson J; Unge G; Ljungqvist A Arzneimittelforschung; 1980; 30(5):791-2. PubMed ID: 6156689 [TBL] [Abstract][Full Text] [Related]
10. Time dependence of dipyridamole-induced increase in skeletal muscle capillarization. Adolfsson J Arzneimittelforschung; 1986 Dec; 36(12):1768-9. PubMed ID: 3566837 [TBL] [Abstract][Full Text] [Related]
11. The pharmacology of coronarotropic drugs using dipyridamole as an example. Kadatz R Brux Med; 1970 Sep; 50(9):609-16. PubMed ID: 5510361 [No Abstract] [Full Text] [Related]
12. Augmentation of coronary collaterals and protection against the consequences of coronary ligation following the administration of dipyridamole. Schmier J; Kaden F; Schmidt HD Brux Med; 1970 Sep; 50(9):617-22. PubMed ID: 5510362 [No Abstract] [Full Text] [Related]
13. [The influence of long term dipyridamole application on the coronary flow and isoproterenol and papaverine effects on the isolated hearts of small mammals]. Mentz P; Förster W; Wartner U Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):317-24. PubMed ID: 4778622 [No Abstract] [Full Text] [Related]
14. Pentaerythritoltetranitrate and dipyridamole on cardiac nutritive flow and blood content. Winbury MM; Losada M; Kissil D; Howe BB; Pensinger RR Am J Physiol; 1971 May; 220(5):1558-63. PubMed ID: 5574677 [No Abstract] [Full Text] [Related]
15. [Maximal dilatation of the coronary bed using dipyridamole in the diagnosis of coronary insufficiency]. Cerný J; Kandus J; Cerný P Vnitr Lek; 1989 Sep; 35(9):913-20. PubMed ID: 2815606 [TBL] [Abstract][Full Text] [Related]
16. [Ultrastructural study of the myocardium of rats treated with dipyridamole and subjected to swimming exercises]. Jiménez-Castellanos MR; Moreno J; López-Campos JL Rev Clin Esp; 1984 Sep; 174(6):237-41. PubMed ID: 6522705 [No Abstract] [Full Text] [Related]
17. Effect of nitroglycerin and dipyridamole on regional coronary resistance. Fam WM; McGregor M Circ Res; 1968 May; 22(5):649-59. PubMed ID: 4967491 [No Abstract] [Full Text] [Related]